Produktinformation
- N2-[1,4-Dioxo-4-[[4-(4-oxo-8-phenyl-4H-1-benzopyran-2-yl)morpholinium-4-yl]methoxy]butyl]-L-arginylglycyl-L-α-aspartyl-L-serine
- inn er salt
SF 1126 is a potent inhibitor of the PI3K/Akt/mTOR signaling pathway, which plays a crucial role in regulating cell growth and survival. This compound induces apoptosis in cancer cells by inhibiting the activity of kinase enzymes that are involved in tumor progression. SF 1126 has been shown to inhibit the secretion of secretin, a hormone that stimulates pancreatic exocrine secretion, and also inhibits xylanase activity. This compound has demonstrated antitumor effects against various types of cancer, including breast, lung, and colon cancer. Additionally, SF 1126 has been found to be an analog of saxagliptin and aprepitant, two drugs used for the treatment of diabetes and chemotherapy-induced nausea and vomiting respectively. The potential therapeutic benefits of SF 1126 make it a promising candidate for the development of new cancer treatments.
Chemische Eigenschaften
Technische Anfrage zu: 3D-BS183202 SF 1126
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
